AMGEN INC — Director's Dealing 2018

Dec 11, 2018

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: AMGEN INC (AMGN)
CIK: 0000318154
Period of Report: 2018-12-06

Reporting Person: Jacks Tyler (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2018-12-06	Common Stock	M	20000	$82.60	Acquired	28979	Direct
2018-12-06	Common Stock	S	20000	$195.4116	Disposed	8979	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2018-12-06	Nqso (Right to Buy)	$82.60	M	20000	Disposed	2022-07-31	Common Stock (20000)	Direct

Footnotes

F1: The price reported is an average price. the prices ranged from $195.28 to $195.83 per share for this cashless exercise of 20,000 stock options expiring July 31, 2022. Full information regarding the number of shares sold at each separate price within the range set forth above is available upon request by the SEC staff, the issuer or a security holder of the issuer.

F2: These shares include 467 Dividend Equivalents (DEs) granted pursuant to the Director Program and subject to a qualifying dividend reinvestment plan. DEs are credited on the director's vested but deferred RSUs and are paid out in shares of the Company's Common Stock on a one-to-one basis along with a cash payment for any remaining fractional share amount.